Minimally invasive heart valve surgery has evolved significantly over the past 10 years and now comprises safe and efficient operations for most patients. The main goals of minimally invasive heart valve surgery are to reduce surgical trauma, increase patient satisfaction, reduce morbidity, and lower costs while still providing durable and safe valve repair or replacement. After a decade of refinements, studies have shown that minimally invasive heart valve surgery is a safe and effective procedure with similar if not improved perioperative morbidity and mortality rates compared with conventional valve surgery. Patients derive a variety of tangible benefits from these new surgical approaches, including less pain, shorter lengths of hospital stay, and faster return to preoperative functional levels. Minimally invasive heart valve surgery should be an option for any patient undergoing heart valve surgery today.
C urrent techniques of valve surgery trace their origins to the early 20th century when Tuffier effectively dilated a stenotic aortic valve by invaginating the aorta in 1913. A hiatus of many years and countless experimental studies followed before the development of the heart-lung machine by Gibbon ushered in the modern era of valve surgery and allowed Harken in 1960 to implant the first successful mechanical valve in a patient with severe aortic regurgitation. The ensuing years witnessed the rapid development of a variety of valvular prostheses but little change in the operative technique of valve surgery, namely full sternotomy with cardiopulmonary bypass. Traditionally, open heart surgery for valve replacement or repair involved a significant physiological and psychologic insult as a result of the combined effects of a full midline sternotomy and the use of cardiopulmonary bypass with cardioplegic arrest. In the early 1990s, however, the success of laparoscopic cholecystectomy with its clear benefits compared with traditional open surgery reawakened surgeons' and their patients' interest in mini-mally invasive approaches and led to the rapid development of minimally invasive cardiac surgery. With this impetus, Cosgrove and Sabik 1 and Cohn et al 2 modified the traditional approach to heart valve surgery to allow safe, direct-access valve repairs and replacements through smaller incisions. The main goals of minimally invasive valve surgery are to reduce surgical trauma, increase patient satisfaction, reduce morbidity, and lower costs while still providing durable and safe valve repairs or replacements. Today, minimally invasive methods for valve surgery have been implemented at many institutions and have evolved into safe, efficient options for most patients.
Minimally invasive valve surgery represents a significant paradigm shift within the field of cardiac surgery. Traditionalists were initially skeptical of such techniques, claiming that smaller incisions might lead to inferior results and unsafe operations, especially from retained intracardiac air. 3 Yet, the rapid development and refinement of techniques have led to the realization that the minimally invasive approach does not compromise surgical exposure and enables the performance of all types of complex valve procedures without additional risk. 4
TECHNIQUES OF MINIMALLY INVASIVE VALVE SURGERY
Minimally invasive valve surgery does not refer to 1 specific novel surgical approach, but rather to a collection of new techniques and operation-specific technologies directed at minimizing surgical trauma. Unlike coronary artery surgery in which the term "minimally invasive" can refer to the avoidance of cardiopulmonary bypass (eg, off-pump coronary artery bypass surgery), heart valve surgery is presently dependent on the use of extracorporeal circulation. Thus, the goal of minimally invasive valve surgery is to limit surgical trauma by using smaller incisions.
Various incisions have been used for minimally invasive heart valve surgery (Fig. 1 ). The first truly minimally invasive valve surgeries performed in 1996 by Cosgrove and associates 1 and Cohn and colleagues 2,5,6 used parasternal or transsternal incisions. With additional experience, these incisions were abandoned because of their slower healing rate, increased incidence of lung herniation, and cosmetically less appealing results. These initial approaches were eventually supplanted by either a hemisternotomy or minithoracotomy incision. 7 Although most minimally invasive valve surgeries were performed under direct vision, some groups began using video assistance for certain situations. Carpentier performed the first video-assisted mitral valve repair through a minitho-racotomy under hypothermic ventricular fibrillation. 8 Soon thereafter, Chitwood did the same using a transthoracic aortic clamp and retrograde cardioplegia. 9 Greater comfort with endoscopic surgery led to the development of video-directed heart valve surgery in which the majority of the valve procedure is performed while viewing a video monitor. In 1998, Carpentier and associates performed the first totally robotic mitral valve repair using the da Vinci surgical system (Intuitive Surgical, Sunnyvale, CA). 10 This same system continues to be used at other institutions with excellent results. 11 An important adjunct to the development of minimally invasive valve surgery has been the parallel progress in perfusion technology. Smaller, nonkinking arterial and venous cannulas have been combined with vacuum-assisted venous drainage to allow for maximal utilization of space provided by small incisions. Transjugular coronary sinus catheters are also used in select situations, and carbon dioxide (CO 2 ) is directed into the operative field to limit the development of intracardiac air. Finally, the routine use of intraoperative transesophageal echocardiography allows for realtime online monitoring for cardiac distension, deairing, and cannula placement. 12 Minimally invasive valve surgery requires a carefully orchestrated coordination of efforts of the surgeon, perfusionist, and anesthesiologist.
Our approach to minimally invasive aortic valve surgery at the Brigham and Women's Hospital uses a 6-cm skin incision beginning halfway between the sternal notch and the angle of Louis. 4 An upper hemisternotomy is then performed from the sternal notch inferiorly to the right fourth intercostal space, forming a reversed L-shaped hemisternotomy ( Fig.  2A) . The pericardium is suspended to the skin edges effectively elevating the ascending aorta out of the chest cavity. Cardiopulmonary bypass is established by cannulating the distal ascending aorta and right atrium. Venous cannulation is performed with a long, small (21-F) venous cannula, which is placed percutaneously in the femoral vein and advanced under transesophageal guidance to the right atrium. Continuous CO 2 insufflation of the incision has been particularly advantageous in minimizing intracardiac air and shortening deairing at the conclusion of the case. After institution of cardiopulmonary bypass, aortic crossclamping, and antegrade cardioplegia delivery, the aortic valve replacement proceeds under direct vision as it would in a full sternotomy case ( Fig.  2B , C). This incision has also been used for ascending aortic replacements. 13, 14 In our cohort of patients undergoing reoperative aortic valve surgery with a patent left internal mammary artery (LIMA) graft, we cannulate the right axillary 
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Cardiology in Review • Volume 15, Number 3, May/June 2007 artery and limit our mediastinal dissection to the aorta to enable clamping and aortotomy 7, 15 (Fig. 3A-C ). This procedure is performed under moderate to deep hypothermia (20 -22°C) with antegrade cardioplegia delivery but no dissection of the LIMA pedicle. In some instances, a transjugular coronary sinus catheter is used for retrograde cardioplegia delivery.
Minimally invasive mitral valve surgery can be performed either through a hemisternotomy or various forms of a minithoracotomy. 16 -21 We have gained considerable experience with a lower hemisternotomy using a 6-cm incision overlying the inferior aspect of the sternum. The sternotomy extends from the sternoxiphoid junction to the right second intercostal space (Fig. 4A ). The ascending aorta is cannulated using a 14-F arterial cannula placed using Seldinger technique and the femoral vein is cannulated with showing ascending aortic cannula, crossclamp, and cardioplegia cannula. Percutaneous femoral cannula terminates at the right atrium-superior vena cava junction; (C) after dissection of Sondergaard's interatrial groove, the left atrium is opened, and the mitral valve exposed with the use of a Cosgrove retractor. 4B ). Exposure of the mitral valve through Sondergaard's groove optimizes visualization and avoids conduction abnormalities and air entrainment into the right heart as is often associated with the transseptal approach (Fig. 4C ). Tricuspid valve surgery can be performed easily through this incision so long as an additional small superior vena cava cannula is placed and both cavae are isolated. Robotic and video-assisted mitral valve surgery is performed through a right nonspreading minithoracotomy with port-access perfusion technology 22 (Fig. 5 ). Although this incision is clearly smaller than a hemisternotomy, the topography of the valve differs from the conventional sternotomy approach and may be unfamiliar to those not trained in this exposure.
ADVANTAGES OF MINIMALLY INVASIVE VALVE SURGERY
The impetus for the development and refinement of minimally invasive valve surgery has been the belief that smaller incisions result in reduced surgical trauma and less blood loss, thus translating into less pain, faster recovery, less cost, and an overall savings of healthcare resources. Skepticism surrounding the use of minimally invasive valve surgery has focused on the potential "tradeoff" of surgical incision and limited exposure for the safety of well-established traditional full sternotomy approaches. With experience in these procedures, centers with large volumes report similar operative times with minimally invasive approaches compared with conventional surgery. 23, 24 Comparing 189 minimally invasive with a similar number of conventional aortic valve surgeries, Sharony et al reported similar bypass and crossclamp times between the 2 groups. 25 At our institution, cardiopulmonary bypass time in minimally invasive aortic and mitral valve surgeries is actually significantly shorter than conventional surgeries. 4 Like with any new operative procedure, there is clearly a learning curve for these new approaches, which influences outcomes and likely accounts for the longer operative times at institutions with less experience in these new methods. Nevertheless, high-volume centers have proven that minimally invasive valve surgery can be performed just as safely and expeditiously as traditional valve surgery with respect to operative times.
Conventional aortic and mitral valve surgery has low operative mortality. According to the Society of Thoracic Surgery National Database Fall 2005 Executive Summary, the unadjusted operative mortality for aortic and mitral valve replacement was approximately 3.5% and 6.0%, respectively, whereas the unadjusted mortality for mitral valve repair was approximately 1.75%. 26 Most all studies of minimally invasive valve surgery have reported comparable early mortality rates, suggesting that minimally invasive valve surgery is at least as good as conventional approaches with regard to operative mortality.
Studies comparing minimally invasive with conventional valve surgery have documented a relatively consistent reduction in postoperative hemorrhage. In a prospective, randomized trial, Dogan et al showed a significant reduction in postoperative chest tube output in the minimally invasive surgery group compared with the conventional group (240 Ϯ 69 mL vs. 495 Ϯ 165 mL, P ϭ 0.008). 24 Other studies have documented fewer blood product transfusion requirements for minimally invasive surgeries, yet in most cases, these data are not risk-adjusted. 17, 27 Finally, some studies found no difference in transfusion requirements; whether this is a result of an inadequate number of patients is difficult to ascertain. 28 The overall reduction in surgical trauma with minimally invasive approaches has been shown to reduce postoperative pain, improve length of stay, and reduce utilization of postoperative rehabilitation facilities. Candaele et al found that patients who underwent an upper hemisternotomy had significantly less postoperative pain than those who had conventional full sternotomies. 29 Pain scores were evaluated with a structured questionnaire at 4 days and 1 month after surgery. Differences in pain scores between the groups were still evident at 1 month, whereas narcotic utilization was similar, suggesting that minimally invasive valve approaches result in less perceived postoperative pain. Significantly decreased length of hospital stay and greater proportion of home discharges have been consistent findings in almost all reports on minimally invasive valve surgery. In our data from 1000 minimally invasive valve operations between 1996 and 2003, we demonstrated significant differences in both the median length of stay as well as in discharges home in both minimally invasive aortic (6 vs. 7, P Ͻ 0.01; 380 vs. 337, P Ͻ 0.01) and mitral (5 vs. 7, P Ͻ 0.01; 433 vs. 226, P Ͻ 0.01) valve surgery. 4 To adjust for any selection bias, Sharony et al compared 233 patients who underwent minimally invasive aortic valve replacement with a similar number of propensitymatched conventional approach controls. 30 They found that the median length of stay was shorter with minimally invasive aortic valve surgery (6 vs. 8 days; P Ͻ 0.001) and that a greater percentage of patients undergoing minimally invasive valve surgery were discharged home rather than sent to rehabilitation facilities or nursing homes (65.7% vs. 52.9%; P ϭ 0.05). Although no studies have rigorously evaluated cost data for minimally invasive valve surgery, length of stay is a known surrogate for resource utilization and hospital costs. Shorter lengths of stay most definitely reduce hospital resources and costs. 31 Minimally invasive aortic valve surgery has also been used in patients who have undergone previous sternotomies. 7, 32 Because primary minimally invasive approaches have been shown to minimize surgical trauma, Byrne et al hypothesized that these same benefits might translate to the patient who has had a previous sternotomy. 33 In a retrospective analysis of 9 patients who underwent conventional full sternotomy and 20 patients who underwent partial hemisternotomy for isolated elective reoperative aortic valve replacement, conventional full resternotomy remained a risk factor for greater blood loss (odds ratio ϭ 5.7, P ϭ 0.06), greater transfusion requirement (odds ratio ϭ 2.4, P ϭ 0.25), and longer total operative duration (odds ratio ϭ 7.7, P ϭ 0.03) compared with partial hemisternotomy. Partial upper hemisternotomy for reoperative aortic valve replacement avoids unnecessary lower mediastinal dissection, thereby reducing blood loss, transfusion needs, and total operative duration. These beneficial effects, which are accomplished without compromising the efficacy of the valve operation, make the partial upper hemisternotomy an excellent alternative to conventional full resternotomy for reoperative aortic valve replacement.
OUTCOMES OF MINIMALLY INVASIVE VALVE SURGERY: THE BRIGHAM EXPERIENCE
From July 1996 through January 2006, a total of 1553 minimally invasive valve surgeries were performed at the Brigham and Women's Hospital, 890 of which were aortic and 663 mitral. This series represents one of the largest single institutional experiences in the world. Over the past 10 years, refinement of surgical technique, improvements in perfusion technology, and expansion of intraoperative transesophageal echocardiography capabilities have allowed us to perform minimally invasive valve surgery with very low morbidity and mortality.
Minimally Invasive Aortic Valve Surgery
Of the 890 minimally invasive aortic valve surgeries, 875 were for replacement and 15 for repair of the aortic valve. The right parasternal approach, used in the initial 33 patients, was supplanted by the current standard upper hemisternotomy in the remaining patients. Mean age of the patient population was 65 years (range, 24 -95 years) with a maleto-female ratio of 3:2. Thirty-four percent of the patients were either New York Heart Association functional class III or IV and 115 had prior sternotomies. Overall 30-day operative mortality for this entire group was 2% (18 of 890), significantly lower than risk-unadjusted mortality for aortic valve replacement from the STS National Database (3.4 -4.4%). Postoperative bleeding requiring reoperation occurred in 2.6% (23 of 890) and 50% of patients required blood transfusion with mean transfusion of 1.8 units per patient. In late 2004, Mihaljevic et al reported on the initial 526 patients of this group and found a similar operative mortality of 2% (12 of 526). 4 Complications in this earlier published series included stroke (2%), deep sternal wound infection (1%), heart block (5%), and bleeding requiring reoperation (3%). Median length of stay was 6 days with 20% of patients being discharged on day 4 or earlier. With a median follow up at that time of 39 months, there were 24 of 526 deaths in the follow-up period for an actuarial survival of 98%, 94%, and 82% at 1, 3, and 5 years, respectively.
To date, minimally invasive reoperative aortic valve replacement has been performed in 115 patients. Previous studies have identified advanced age as a predictor of poor outcome after conventional AVR. 34 Our data in octo-and nonoctogenarians (age Ն80 years) reveals exceptionally good survival for this age group suggesting that the benefits of minimally invasive valve surgery may be magnified in higher risk subgroups. Of 890 total minimally invasive aortic valve surgeries, 157 were performed on patients 80 years old or older (mean age, 84 years). Operative mortality in this group was 1.9% (3 of 157). There was no mortality in the 34 octogenarians who underwent a minimally invasive reoperative aortic valve replacement. Our 10-year outcome data on minimally invasive aortic valve surgery clearly demonstrate the appropriateness of this approach for primary and reoperative aortic valve surgery in all age groups. Our technique of direct access surgery provides excellent, safe, and familiar exposure of the aortic valve and has become our standard for these procedures at the Brigham and Women's Hospital.
Minimally Invasive Mitral Valve Surgery
Of the 663 patients who underwent a minimally invasive approach for mitral valve surgery since July 1996, the majority (90%) received mitral valve repair. The majority of cases were approached through a lower hemisternotmy. Mean age of the patient population was 57 years (range, 17-90 years) with a male-to-female ratio of 3:2. Twenty-seven percent of the patients were either New York Heart Association functional class III or IV and 8 had prior sternotomies. Mitral valve pathology varied among myxomatous valve disease (83%), rheumatic (9%), endocarditis (4%), functional dilatation (4%), calcific degeneration (Ͻ1%), and ischemic (Ͻ1%). Overall 30-day operative mortality for this entire group was 0.7% (5 of 663), with 3% (2 of 64) in the MVR subgroup and 0.5% (3 of 599) in the mitral valve repair (MVP) group. Mihaljevic et al reported on the initial 474 patients of this group and found an operative mortality of 0.2% (1 of 474). Complications in this earlier published series included stroke (1%), deep sternal wound infection (1%), heart block (2%), and bleeding requiring reoperation (2%). Median length of stay was 5 days with 29% of patients being discharged on day 4 or earlier. With a median follow up at that time of 42 months, there were 16 of 474 deaths in the follow-up period for an actuarial survival of 98%, 97%, and 95% at 1, 3, and 5 years, respectively.
ROBOTIC MITRAL VALVE SURGERY
Recent advances in surgical robotic systems have allowed for manipulation of tissues within a small fixed space through the use of 3-dimensional vision and microinstrumentation providing a full range of motion. In a prospective phase II US Food and Drug Administration trial, robotic mitral valve repairs were performed in 112 patients at 10 centers using the da Vinci surgical system. 11 Instruments were positioned in the chest through 1-cm incisions, whereas a 4-cm incision was used for the camera and prosthesis passage. The average age was 56.4 Ϯ 0.09 years (mean Ϯ standard error of mean) with 69% men. Valve pathology was myxomatous degeneration in the majority (91%). Leaflet repair times averaged 36.7 Ϯ 0.2 minutes with annuloplasty times of 39.6 Ϯ 0.1 minutes. Total robot, aortic crossclamp, and cardiopulmonary bypass times were 77.9 Ϯ 0.3 minutes, 126 Ϯ 6 minutes, and 168 Ϯ 6 minutes, respectively. Transthoracic echocardiography performed 1 month after surgery demonstrated 2ϩ re-sidual mitral regurgitation in 8.0% of patients; 75% of these patients with 2ϩ residual mitral regurgitation required reoperation. There were no deaths, strokes, or device-related complications. This phase II multicenter trial demonstrated that robotic mitral valve surgery is safe and durable despite a considerably steep learning curve.
COMBINED PERCUTANOUS CORONARY INTERVENTION AND MINIMIALLY INVASIVE VALVE SURGERY
Recent advances in percutaneous coronary interventions (PCI) and the development of drug-eluting stents have led to improved patency and low periprocedural morbidity. Because minimally invasive valve surgery offers significant improvements in perioperative outcomes, the application of PCI with concomitant minimally invasive valve surgery may prove advantageous in those situations in which combined CABG/valve surgery would otherwise be needed. 35 In patients who need reoperative CABG/valve surgery, the use of preoperative PCI permits the use of a minimally invasive approach that limits hazardous mediastinal dissection. In patients who have left main stenosis or significant left anterior descending stenosis, a full sternotomy is indicated so as to allow the use of a LIMA graft and derive its excellent survival benefits. Byrne and colleagues note that the tradeoff for such an approach is the increased amount of bleeding resulting from the use of antiplatelet agents. 36 The incidence of bleeding can be decreased by performing minimally invasive valve surgery and PCI concurrently.
CONCLUSIONS
Minimally invasive heart valve surgery has undergone a decade of refinements since its inception in 1996. Repeated studies have shown that minimally invasive valve surgery is a safe and effective procedure with similar if not improved morbidity and mortality rates compared with conventional valve surgery. There is clearly evidence for a learning curve in the performance of these procedures. Once this learning curve is negotiated with a requisite number of cases, operative times are equivalent if not shorter for minimally invasive approaches compared with conventional surgery.
The overall goal of minimally invasive heart valve surgery is to limit surgical trauma by miniaturizing incisions while still maintaining the same high quality of operation afforded by traditional open techniques. Studies have shown that patients derive a variety of tangible benefits from these new surgical approaches. Patients have less pain, leave the hospital sooner, and return to preoperative functional levels sooner than comparable patients who had traditional valve surgery. All of these benefits translate into improved utilization of limited healthcare resources.
